Yubin Kang

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Top Venues

Science advances

Journal of hematology & oncology

Cancer medicine

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoyi Zhu, Qiang Huang, Lai-Ming Jiang, Van-Tu Nguyen, Tri Vu, Garth Devlin, Jabbar Shaima, Xiaobei Wang, Yong Chen, Lijun Ma, Kun Xiang, Ergang Wang, Qiangzhou Rong, Qifa Zhou, Yubin Kang, Aravind Asokan, Liping Feng, Shiao-Wen D Hsu, Xiling Shen, Junjie Yao
Longitudinal intravital imaging of mouse placenta. Science advances 10 (12) (2024)
Xiaoyi Zhu, Qiang Huang, Lai-Ming Jiang, Van-Tu Nguyen, Tri Vu, Garth Devlin, Jabbar Shaima, Xiaobei Wang, Yong Chen, Lijun Ma, Kun Xiang, Ergang Wang, Qiangzhou Rong, Qifa Zhou, Yubin Kang, Aravind Asokan, Liping Feng, Shiao-Wen D Hsu, Xiling Shen, Junjie Yao
Longitudinal intravital imaging of mouse placenta. Science advances 10 (12) (2024)
Xiaoyi Zhu, Qiang Huang, Lai-Ming Jiang, Van-Tu Nguyen, Tri Vu, Garth Devlin, Jabbar Shaima, Xiaobei Wang, Yong Chen, Lijun Ma, Kun Xiang, Ergang Wang, Qiangzhou Rong, Qifa Zhou, Yubin Kang, Aravind Asokan, Liping Feng, Shiao-Wen D Hsu, Xiling Shen, Junjie Yao
Longitudinal intravital imaging of mouse placenta. Science advances 10 (12) (2024)
Yubin Kang, Pasupathi Sundaramoorthy, Cristina Gasparetto, Daniel Feinberg, Shengjun Fan, Gwynn Long, Emily Sellars, Anderson Garrett, Sascha A Tuchman, Brandi N Reeves, Zhiguo Li, Bei Liu, Besim Ogretmen, Lynn Maines, Vered Katz Ben-Yair, Charles Smith, Terry Plasse
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma. Annals of hematology (2022)
Barry Paul, Yue Zhao, Gavin Loitsch, Daniel Feinberg, Parker Mathews, Ian Barak, Megan Dupuis, Zhiguo Li, Lindsay Rein, Endi Wang, Yubin Kang
The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors. Cancer medicine 9 (16) (2020)
Qiang Huang, Malkiel A Cohen, Fernando C Alsina, Garth Devlin, Aliesha D O'Raw, Jennifer McKey, Patrick Havlik, Nikolai Rakhilin, Ergang Wang, Kun Xiang, Parker Mathews, Lihua Wang, Cheryl Bock, Victor A Ruthig, Yi Wang, Marcos Negrete, Chi Wut Wong, Preetish K L Murthy, Shupei Zhang, Andrea R Daniel, David G Kirsch, Yubin Kang, Blanche Capel, Aravind Asokan, Debra L Silver, Rudolf Jaenisch, Xiling Shen
Intravital imaging of mouse embryos. Science (New York, N.Y.) 368 (6487) (2020)
Pasupathi Sundaramoorthy, Cristina Gasparetto, Yubin Kang
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation. Cancer medicine (2018)
Zhihong Zheng, Shengjun Fan, Jing Zheng, Wei Huang, Cristina Gasparetto, Nelson J Chao, Jianda Hu, Yubin Kang
Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma. Journal of hematology & oncology 11 (1) (2018)
Ningfei An, Bo Cen, Houjian Cai, Jin H Song, Andrew Kraft, Yubin Kang
Pim1 kinase regulates c-Kit gene translation. Experimental hematology & oncology 5 (2016)
Michael M B Green, Nelson Chao, Saurabh Chhabra, Kelly Corbet, Cristina Gasparetto, Ari Horwitz, Zhiguo Li, Jagadish Kummetha Venkata, Gwynn Long, Alice Mims, David Rizzieri, Stefanie Sarantopoulos, Robert Stuart, Anthony D Sung, Keith M Sullivan, Luciano Costa, Mitchell Horwitz, Yubin Kang
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery. Journal of hematology & oncology 9 (1) (2016)